All Stories

  1. Supporting Understanding: Comparing Conversational Interviewing in Chatbot vs Human-Administered Patient-Reported Outcomes for Stroke Survivors
  2. Closing the UK care home data gap – methodological challenges and solutions
  3. Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study
  4. Accuracy of Telephone-Based Cognitive Screening Tests: Systematic Review and Meta-Analysis
  5. Who Is Classified as Untestable on Brief Cognitive Screens in an Acute Stroke Setting?
  6. Social engagement after stroke – is it relevant to cognitive function? A cross-sectional analysis of UK Biobank data
  7. Accuracy of the short‐form Montreal Cognitive Assessment: Systematic review and validation
  8. Commentary: Evaluating the Landscape of Clinical Research in Neurosurgery
  9. Stroke prediction and the future of prognosis research
  10. When is Alzheimer’s not dementia—Cochrane commentary on The National Institute on Ageing and Alzheimer’s Association Research Framework for Alzheimer’s Disease
  11. Social engagement after stroke – is it relevant to cognitive function? A cross-sectional analysis of UK Biobank data
  12. Variability of functional outcome measures used in animal models of stroke and vascular cognitive impairment – a review of contemporary studies
  13. Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials
  14. Predicting Discharge to Institutional Long-Term Care After Stroke: A Systematic Review and Metaanalysis
  15. Sit to stand activity during stroke rehabilitation
  16. The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke
  17. Cochrane Dementia Group Turns 21—Older and (Slightly) Wiser
  18. Association between cognition and gene polymorphisms involved in thrombosis and haemostasis
  19. Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research
  20. Associations with publication and assessing publication bias in dementia diagnostic test accuracy studies
  21. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting
  22. Informant single screening questions for delirium and dementia in acute care – a cross-sectional test accuracy pilot study
  23. ‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure
  24. Single screening questions for cognitive impairment in older people: a systematic review
  25. Test Accuracy of Cognitive Screening Tests for Diagnosis of Dementia and Multidomain Cognitive Impairment in Stroke
  26. Depression and anxiety symptoms post-stroke/TIA: prevalence and associations in cross-sectional data from a regional stroke registry
  27. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO
  28. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting
  29. Cog-4 Has Limited Diagnostic Test Accuracy and Validity for Cognitive Assessment in Stroke Survivors
  30. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative
  31. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations
  32. Associations with anticoagulation: a cross-sectional registry-based analysis of stroke survivors with atrial fibrillation
  33. The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good
  34. Feasibility and Diagnostic Accuracy of Early Mood Screening to Diagnose Persisting Clinical Depression/Anxiety Disorder after Stroke
  35. Improving the Efficiency of Stroke Trials
  36. How Well Do Standard Stroke Outcome Measures Reflect Quality of Life?
  37. Test Accuracy of Short Screening Tests for Diagnosis of Delirium or Cognitive Impairment in an Acute Stroke Unit Setting
  38. The Cochrane Collaboration and geriatric medicine
  39. Management of blood pressure in acute stroke
  40. Questionnaire assessment of usual practice in mood and cognitive assessment in Scottish stroke units
  41. Response to Letter Regarding Article, “Prestroke Modified Rankin Stroke Scale Has Moderate Interobserver Reliability and Validity in an Acute Stroke Setting”
  42. Diabetes control in older people
  43. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies
  44. The Modified Graeb Score
  45. Assessment scales in stroke: clinimetric and clinical considerations
  46. Reliability (Inter-rater Agreement) of the Barthel Index for Assessment of Stroke Survivors
  47. Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
  48. Principles of rehabilitation of older people
  49. Prestroke Modified Rankin Stroke Scale Has Moderate Interobserver Reliability and Validity in an Acute Stroke Setting
  50. Cardiac Ageing and Systemic Disorders
  51. Planning Cardiovascular Investigations and Management of Older People
  52. Novel lytics, novel imaging: a new treatment strategy in stroke?
  53. Subclinical thyroid disorders
  54. Responses to acute stroke: beyond urgent imaging and systemic thrombolysis, where to now?
  55. Cognitive and Mood Assessment in Stroke Research
  56. Cardiac Ageing and Systemic Disorders
  57. Nonpharmacological Interventions for Caregivers of Stroke Survivors
  58. Properties of Proxy-Derived Modified Rankin Scale Assessment
  59. Making the call: is telestroke cost effective?
  60. Non-pharmacological interventions for caregivers of stroke survivors
  61. Physical Activity in the Prevention and Treatment of Stroke
  62. Functional assessment in older people
  63. Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta‐analyzes
  64. Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta‐Analysis
  65. Post-acute care and secondary prevention after ischaemic stroke
  66. Barthel Index for Stroke Trials
  67. Do integrated stroke services impact on the ‘cost’ of stroke?
  68. Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase
  69. Long-Term Outcome following Attendance at a Transient Ischemic Attack Clinic
  70. Neckties and Cerebrovascular Reactivity in Young Healthy Males: A Pilot Randomised Crossover Trial
  71. Reliability of Structured Modified Rankin Scale Assessment
  72. Emergency Hospital Admissions from Care-Homes: Who, Why and What Happens? A Cross-Sectional Study
  73. Sugar and Stroke: Cerebrovascular Disease and Blood Glucose Control
  74. Application of quality-of-life measurements in clinical trials and in clinical practice for gynecologic cancer patients
  75. Acute ‘strokenomics’: efficacy and economic analyses of alteplase for acute ischemic stroke
  76. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial
  77. Reliability of the Modified Rankin Scale
  78. Functional Outcome Measures in Contemporary Stroke Trials
  79. Response to Letter by Ray et al
  80. ABCD2 Scores and Prediction of Noncerebrovascular Diagnoses in an Outpatient Population
  81. Exploring the Reliability of the Modified Rankin Scale
  82. Evidence-based stroke rehabilitation: an expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008
  83. A recognition tool for transient ischaemic attack
  84. Hyperglycaemia in Acute Stroke – To Treat or Not to Treat
  85. Deriving Modified Rankin Scores From Medical Case-Records
  86. Variability in Modified Rankin Scoring Across a Large Cohort of International Observers
  87. Hypertension in acute stroke
  88. A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence?
  89. Response to Letter by Proctor
  90. Advances in Emerging Therapies 2007
  91. Past, present and future of alteplase for acute ischemic stroke
  92. The Continued Yin and Yang of Uric Acid
  93. Time Spent at Home Poststroke
  94. European Stroke Conference, Glasgow, UK, May 29–June 1, 2007
  95. Reliability of the Modified Rankin Scale
  96. Response to Letter by Quinn et al
  97. Initial Experience of a Digital Training Resource for Modified Rankin Scale Assessment in Clinical Trials
  98. Acute stroke: we have the treatments and we have the evidence – we need to use them
  99. There is no evidence of an association in children and teenagers between the apolipoprotein E ɛ4 allele and post‐traumatic brain swelling